drugset / Trial / NCT06855043
Little Lungs Study
Phase 1/2
Not yet recruiting
24 enrolled
University of Wisconsin, Madison
Meriter Foundation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This clinical trial is being done to evaluate the safety and clinical response of late surfactant treatment with budesonide in extremely preterm infants requiring mechanical ventilation at 7-14 days of age.
Timeline
- Start
- 2026-09
- Primary completion
- 2029-03
- Completion
- 2029-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 0.25 mg/kg | Other |
| Subject | Calfactant | Protein / enzyme biologic | 3 unknown | Other |